Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 8, 2012, Pages 3173-3177

  Arinaminpathy, Nimalan ^a   Ratmann, Oliver ^b,c   Koelle, Katia ^b,d   Epstein, Suzanne L ^e   Price, Graeme E ^e   Viboud, Cecile ^d   Miller, Mark A ^d   Grenfell, Bryan T ^a,d  

^a PRINCETON UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; EVOLUTIONARY DEVELOPMENTAL BIOLOGY; HUMAN; IMMUNIZATION; INFLUENZA; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; VACCINATION; VIRUS TRANSMISSION;

ANTIGENS, VIRAL; CROSS PROTECTION; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, IMMUNOLOGICAL; VACCINATION; VIRUS SHEDDING;

EID: 84863407530     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1113342109     Document Type: Article

References (36)

1. Palese P (2004) Influenza: Old and new threats. Nat Med 10(12 Suppl):S82-S87.
2. Fitch WM, Bush RM, Bender CA, Cox NJ (1997) Long term trends in the evolution of H (3) HA1 human influenza type A. Proc Natl Acad Sci USA 94:7712-7718. (Pubitemid 27343715)
3. Carrat F, Flahault A (2007) Influenza vaccine: The challenge of antigenic drift. Vaccine 25:6852-6862. (Pubitemid 47398929)
4. Monto AS, Davenport FM, Napier JA, Francis TJ, Jr. (1969) Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic. Bull World Health Organ 41:537-542.
5. Piedra PA, et al. (2005) Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 23:1540-1548. (Pubitemid 40203391)
6. Reichert TA, et al. (2001) The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344:889-896. (Pubitemid 32224397)
7. Rudenko LG, et al. (1993) Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis 168:881-887. (Pubitemid 23282559)
8. Hurwitz ES, et al. (2000) Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 284: 1677-1682.
9. Fedson DS (2003) Pandemic influenza and the global vaccine supply. Clin Infect Dis 36: 1552-1561.
10. Epstein SL, Price GE (2010) Cross-protective immunity to influenza A viruses. Expert Rev Vaccines 9:1325-1341.
11. Price GE, et al. (2009) Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses. Vaccine 27: 6512-6521.
12. Berthoud TK, et al. (2011) Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis 52:1-7.
13. Wei CJ, et al. (2010) Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329:1060-1064.
14. Corti D, et al. (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333:850-856.
15. Cauchemez S, et al. (2009) Closure of schools during an influenza pandemic. Lancet Infect Dis 9:473-481.
16. Anderson RM, May RM (1992) Infectious Diseases of Humans: Dynamics and Control (Oxford Science Publications) (Oxford Univ Press, Oxford, UK).
17. Yang Y, et al. (2009) The transmissibility and control of pandemic influenza A (H1N1) virus. Science 326:729-733.
18. Mills CE, Robins JM, Lipsitch M (2004) Transmissibility of 1918 pandemic influenza. Nature 432:904-906. (Pubitemid 40037151)
19. Edmunds WJ, Gay NJ, Kretzschmar M, Pebody RG, Wachmann H; ESEN Project. European Sero-epidemiology Network (2000) The pre-vaccination epidemiology of measles, mumps and rubella in Europe: Implications for modelling studies. Epidemiol Infect 125:635-650. (Pubitemid 32156852)
20. Metcalf CJ, Bjørnstad ON, Grenfell BT, Andreasen V (2009) Seasonality and comparative dynamics of six childhood infections in pre-vaccination Copenhagen. Proc Biol Sci 276:4111-4118.
21. Anderson RM, May RM (1985) Vaccination and herd immunity to infectious diseases. Nature 318:323-329. (Pubitemid 16198489)
22. McLean AR, Blower SM (1993) Imperfect vaccines and herd immunity to HIV. Proc Biol Sci 253:9-13. (Pubitemid 23235870)
23. Medlock J, Galvani AP (2009) Optimizing influenza vaccine distribution. Science 325: 1705-1708.
24. Basta NE, Halloran ME, Matrajt L, Longini IMJ, Jr. (2008) Estimating influenza vaccine efficacy from challenge and community-based study data. Am J Epidemiol 168: 1343-1352.
25. McLean AR, Blower SM (1995) Modelling HIV vaccination. Trends Microbiol 3: 458-462.
26. Smith DJ, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376. (Pubitemid 38938148)
27. Koelle K, Cobey S, Grenfell B, Pascual M (2006) Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314:1898-1903. (Pubitemid 46026107)
28. Ferguson NM, Galvani AP, Bush RM (2003) Ecological and immunological determinants of influenza evolution. Nature 422:428-433. (Pubitemid 36411395)
29. Koelle K, Khatri P, Kamradt M, Kepler TB (2010) A two-tiered model for simulating the ecological and evolutionary dynamics of rapidly evolving viruses, with an application to influenza. J R Soc Interface 7:1257-1274.
30. Minayev P, Ferguson N (2009) Incorporating demographic stochasticity into multistrain epidemic models: Application to influenza A. J R Soc Interface 6:989-996.
31. Recker M, Pybus OG, Nee S, Gupta S (2007) The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types. Proc Natl Acad Sci USA 104:7711-7716. (Pubitemid 47185971)
32. Grenfell BT, Bjørnstad ON, Kappey J (2001) Travelling waves and spatial hierarchies in measles epidemics. Nature 414:716-723. (Pubitemid 34000763)
33. Bedford T, Cobey S, Beerli P, Pascual M (2010) Global migration dynamics underlie evolution and persistence of human influenza A (H3N2). PLoS Pathog 6:e1000918.
34. Russell CA, et al. (2008) The global circulation of seasonal influenza A (H3N2) viruses. Science 320:340-346. (Pubitemid 351555652)
35. King AA, Shrestha S, Harvill ET, Bjørnstad ON (2009) Evolution of acute infections and the invasion-persistence trade-off. Am Nat 173:446-455.
36. Tian T, Burrage K (2004) Binomial leap methods for simulating stochastic chemical kinetics. J Chem Phys 121:10356-10364. (Pubitemid 40001577)